Abstract
Get full access to this article
View all access options for this article.
References
1.
Nestle
FO
Kaplan
DH
Barker
J.
Psoriasis . N Engl J Med 2009 ; 361 (5 ): 496–9.
2.
Mehta
NN
Krueger
JG
Etzel
CJ
, et al The immunological basis of psoriasis and its clinical consequences . J Autoimmun 2017 ; 86 : 1 –22 .
3.
Szczepanik
M
Krajewska
M
Kowalewski
M
, et al Plasmapheresis in dermatology: current indications . Clin Dermatol 2020 ; 38 (5 ): 617–24.
4.
Lowes
MA
Suarez-Farinas
M
Krueger
JG
, et al Immunology of psoriasis . Annu Rev Immunol 2014 ; 32 : 227–55.
5.
Takahashi
H
Tsuji
H
Hashimoto
Y
, et al Adhesion molecules in psoriasis: therapeutic implications . Br J Dermatol 2013 ; 168 (2 ): 307–15.
6.
Gupta
M
Madan
A
Verma
R
, et al Plasmapheresis in erythrodermic psoriasis: a case report . Indian J Dermatol 2018 ; 63 (3 ): 245–7.
7.
Singh
RK
Lee
KM
Park
HJ
, et al Therapeutic plasmapheresis for recalcitrant pustular psoriasis . Int J Dermatol 2019 ; 58 (4 ): 447–52.
8.
Kumar
R
Sharma
A
Gupta
S
, et al Plasmapheresis for severe psoriasis: a prospective study . J Clin Apher 2021 ; 36 (2 ): 220–7.
9.
Oliveira
R
Mendes-Bastos
P
Ferrinho
P
, et al Rescue therapy with plasmapheresis in severe psoriasis . Dermatol Ther 2020 ; 33 (3 ): e13379.
10.
Shibuya
H
Kondo
S
Takayama
K
, et al Plasmapheresis as a treatment for erythrodermic psoriasis . Arch Dermatol 2012 ; 148 (9 ): 1075–8.
11.
Rockx
MA
Clark
WF
Churchill
DN
, et al Adverse effects of plasmapheresis: a review . J Clin Apher 2016 ; 31 (4 ): 264–9.
12.
Baldo
A
Cafagna
A
Lupi
F
, et al Complications of plasmapheresis in dermatological diseases . Eur J Dermatol 2019 ; 29 (5 ): 563–70.
13.
Patel
V
Tiwari
R
Bose
P
, et al Immunoglobulin replacement therapy in patients undergoing therapeutic plasmapheresis . Transfus Med Rev 2021 ; 35 (2 ): 86 –92 .